微管相互作用与转运结构域包含蛋白1缺陷通过组织因子介导的凝血导致膀胱癌生存不良
研究利用癌症基因组图谱数据集筛选膀胱癌预后基因,并在2个基因表达综合数据库数据集和1个ArrayExpress数据集中验证,另对80例队列行免疫组化检测。微管相互作用与转运结构域包含蛋白1(MITD1)缺失通过细胞质分裂停滞、未折叠蛋白反应和c-Jun上调组织因子(TF),促进凝血和转移,提示靶向MITD1的治疗价值。
要点
- MITD1是膀胱癌主要预后基因,其缺失显著增加组织因子表达。
- MITD1缺陷经细胞质分裂停滞、未折叠蛋白反应和c-Jun促进TF表达。
- 缺乏MITD1的细胞在实验性转移实验中促进凝血和转移。
核心结论
- 肿瘤预后基因在高凝表型和静脉血栓栓塞发生中具有新作用,凸显抗凝治疗的重要性,并揭示靶向MITD1在膀胱癌中的治疗价值。
研究设计与样本
- 利用癌症基因组图谱数据集检测膀胱癌最显著预后基因,并在2个基因表达综合数据库数据集和1个ArrayExpress数据集中验证。
- 对80例个体队列行免疫组化检测以进一步检验预后基因。
- 对最可靠预后基因,通过基因敲低后行二代测序及细胞和动物实验评估其对凝血的影响。
主要发现
- 微管相互作用与转运结构域包含蛋白1(MITD1)缺失显著增加组织因子(TF)表达。
- MITD1缺陷导致细胞质分裂停滞,进而通过未折叠蛋白反应和c-Jun促进TF表达。
- 敲低未折叠蛋白反应关键激酶IRE1或用c-Jun N末端激酶抑制剂失活c-Jun,减弱了MITD1缺陷或二硫苏糖醇诱导的TF上调。
- 缺乏MITD1的细胞在实验性转移实验中促进凝血和转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with cancer are at an increased risk of developing a hypercoagulative phenotype and venous thromboembolism. However, no clinical trial has yet confirmed that anticoagulant therapy improves cancer prognosis, and the mechanism underlying hypercoagulation in patients with bladder cancer is not well understood. OBJECTIVES: We hypothesized that the prognostic genes affect tumor progression via tumor-mediated coagulation. METHODS: We detected the most significant prognostic genes of bladder cancer with The Cancer Genome Atlas dataset and validated them in 2 Gene Expression Omnibus datasets and 1 ArrayExpress dataset. Immunohistochemical tests were performed on a cohort of 80 individuals to further examine the prognostic genes. For the most reliable prognostic gene, its influence on coagulation was evaluated with gene knockdown followed by next-generation sequencing and cellular and animal experiments. RESULTS: Depletion of microtubule interacting and trafficking domain containing 1 (MITD1), a major prognostic gene of bladder cancer, significantly increased the tissue factor (TF) expression. MITD1 deficiency led to cytokinesis arrest, which, in turn, promoted the TF expression via unfolded protein response and c-Jun. The knockdown of IRE1, an essential kinase of unfolded protein response or the inactivation of c-Jun using c-Jun N-terminal kinase inhibitors weakened MITD1 deficiency- or dithiothreitol-induced TF upregulation. Cells lacking MITD1 promoted coagulation and metastasis in the experimental metastasis assay. CONCLUSION: Our findings suggest the novel role of tumor prognostic genes upon the development of hypercoagulative phenotype and venous thromboembolism, thereby underlining the importance of anticoagulant therapy and shedding light on the therapeutic value of targeting MITD1 in bladder cancer.
引用
- Chen Y, Jiao W, Wang Y, et al. Microtubule interacting and trafficking domain containing 1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer. J Thromb Haemost. 2024. PMID: 38554936. doi:10.1016/j.jtha.2024.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。